Passer au contenu principal
Centre intégré universitaire de santé
et de services sociaux de l'Est-de-l'Île-de-Montréal

Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal

Sylvie Lachance, M.D.

Sylvie Lachance

Hématologue-greffeur, Professeure titulaire de clinique

L'équipe de l’IHOT

Chercheur-clinicien

Contact

Tél. : 514 252-3404

Dre Sylvie Lachance a une expertise en greffe hématopoïétique et thérapie cellulaire et ses champs d’intérêts sont la prévention des complications post-greffe particulièrement la maladie du greffon contre l’hôte et la rechute. La Dre Lachance a développé un programme de formation postdoctoral (DES) en greffe de cellules hématopoïétiques et thérapie cellulaire à l’Université de Montréal ayant conduit à la reconnaissance de ce domaine de compétence ciblée par le Collège royal des médecins et chirurgiens du Canada.

 

  • Directrice du programme de résidence (DES) en hématologie de l’Université de Montréal
  • Directrice du programme de fellowship (DES) en greffe et thérapie cellulaire de l’Université de Montréal
  • Membre du comité de direction de l'IHOT
  • Entrée en poste à l’Hôpital Maisonneuve-Rosemont : 2006

 

Formation :

  • Fellowship en transplantation de cellules souches hématopoïétiques : Université Henri-Mondor, Paris (France), 1992-1995
  • Diplôme d'études avancées en immunologie : Institut Pasteur, Paris (France), 1994
  • Résidences en médecine interne et hématologie : Université de Sherbrooke et Université de Montréal (Canada), 1988-1992
  • Doctorat en médecine : Université de Sherbrooke (Canada), 1983-1987
     

Découvrez ses publications

  • Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

    Mark J. Levis, Mehdi Hamadani, Brent Logan, Richard J. Jones, Anurag K. Singh, Mark Litzow, John R. Wingard, Esperanza B. Papadopoulos, Alexander E. Perl, Robert J. Soiffer , Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L. Uy, Edmund K. Waller, Sumithra Vasu, Melhem Solh, Asmita Mishra, Lori Muffly, Hee-Je Kim, Jan-Henrik Mikesch , Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H. Wei, Guido Marcucci , Nancy L. Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Heather Wittsack , Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi-Bin Chen , Sylvie Lachance , BMT-CTN 1506/MORPHO Study Investigators
    DOI 10.1200/JCO.23.02474 PMID 38471061
    Consulter
  • Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development

    Dennis Dong Hwan Kim, Gizelle Popradi, Kylie Lepic, Kristjan Paulson, David Allan, Ram Vasudevan Nampoothiri , Sylvie Lachance , Uday Deotare, Jennifer White, Mohamed Elemary, Kareem Jamani, Christina Fraga, Christopher Lemieux, Igor Novitzky-Basso, Arjun Datt Law, Rajat Kumar, Irwin Walker, Kirk R. Schultz , on behalf of the CTTC Chronic GVHD Guideline Working Group
    DOI 10.3390/curroncol31030108 PMID 38534941
    Consulter
  • Improved outcomes of UM171-expanded cord blood transplantation compared with other graft sources: real-world evidence

    Sandra Cohen , Nadia Bambace , Imran Ahmad , Jean Roy , Xiaoying Tang, Mei-Jie Zhang, Linda Burns, Frédéric Barabé , Léa Bernard , Jean-Sébastien Delisle , Thomas Kiss , Sylvie Lachance , Denis-Claude Roy , Olivier Veilleux , Guy Sauvageau
    DOI 10.1182/bloodadvances.2023010599 PMID 37467030
    Consulter
  • Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD

    DOI 10.1016/j.jtct.2022.10.022 PMID 36334654
    Consulter
  • Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge

    Sylvie Lachance , Alex Bourguignon, Josie-Anne Boisjoly, Philippe Bouchard , Imran Ahmad , Nadia Bambace , Léa Bernard , Sandra Cohen , Jean-Sébastien Delisle , Isabelle Fleury , Thomas Kiss , Luigina Mollica , Denis-Claude Roy , Guy Sauvageau , Olivier Veilleux , Justine Zehr, Miguel Chagnon , Jean Roy
    DOI 10.1016/j.jtct.2022.10.003 PMID 36243319
    Consulter
  • Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment

    Yasmina Serroukh , Josée Hébert , Lambert Busque , François Mercier , Chris Rudd , Sarit Assouline , Sylvie Lachance , Jean-Sébastien Delisle
    DOI 10.1016/j.blre.2022.100991 PMID 35941029
    Consulter
  • Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome

    DOI 10.3390/curroncol29080470 PMID 36005208
    Consulter
  • Two types of human TCR differentially regulate reactivity to self and non-self antigens

    Assya Trofimov, Philippe Brouillard, Jean-David Larouche, Jonathan Séguin, Jean-Philippe Laverdure, Ann Brasey, Gregory Ehx , Denis-Claude Roy , Lambert Busque , Sylvie Lachance , Sébastien Lemieux, Claude Perreault
    DOI 10.1016/j.isci.2022.104968 PMID 36111255
    Consulter
  • Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective

    DOI 10.1016/j.jtct.2021.12.005 PMID 34954149
    Consulter
  • Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study

    Richard LeBlanc , Imran Ahmad , Rafik Terra, Jean-Samuel Boudreault, David Ogez, Kristopher Lamore , Jean-Sébastien Delisle , Nadia Bambace , Léa Bernard , Sandra Cohen , Thomas Kiss , Sylvie Lachance , Séverine Landais, Émilie Lemieux-Blanchard , Guy Sauvageau , Michael Sebag , Denis-Claude Roy , Jean Roy
    DOI 10.1038/s41409-021-01532-2 PMID 34845367
    Consulter
  • Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome

    Alex F. Herrera, Kwang Woo Ahn, Carlos Litovich, Yue Chen, Amer Assal, Qaiser Bashir, Ruthee-Lu Bayer, Melanie Coleman, Zachariah DeFilipp, Nosha Farhadfar, Matthew Greenwood, Theresa Hahn, Mitchell Horwitz, Caron Jacobson, Samantha Jaglowski , Sylvie Lachance , Amelia Langston, Bassam Mattar, Richard T. Maziarz, Joseph McGuirk, Mohammad A. H. Mian, Sunita Nathan, Adrienne Phillips, Kevin Rakszawski, Henrik Sengeloev, Shalini Shenoy, Robert Stuart, Craig S. Sauter, Mohamed A. Kharfan-Dabaja, Mehdi Hamadani
    DOI 10.1182/bloodadvances.2021004865 PMID 34496026
    Consulter
  • Recognition of Hematopoietic Stem Cell Transplantation and Cellular Therapy Expertise to Promote Care Accessibility: A Formally Credentialed Area of Focused Competence in Canada

    Sylvie Lachance , Marcio M Gomes, Nadia M Bambace, Henrique Bittencourt, Kylie Lepic, Mona Shafey, Jolanta Karpinski, Gregory M T Guilcher
    DOI 10.1016/j.jtct.2021.06.013 PMID 34153503
    Consulter
  • How Can We Raise Awareness of Physician's Needs in Order to Increase Adherence to Management and Leadership Training?

    Christian Voirol, Marie-France Pelland, Julie Lajeunesse, Jean Pelletier, Rejean Duplain, Josee Dubois , Sylvie Lachance , Carole Lambert, Julia Sader, Marie-Claude Audetat
    DOI 10.2147/JHL.S288199 PMID 33953630
    Consulter
  • UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections

    Maude Dumont-Lagacé, Qi Li , Mégane Tanguay , Jalila Chagraoui, Tibila Kientega, Guillaume B Cardin, Ann Brasey, Assya Trofimov, Cédric Carli , Imran Ahmad , Nadia M Bambace , Léa Bernard , Thomas Kiss , Jean Roy , Denis-Claude Roy , Sébastien Lemieux, Claude Perreault, Francis Rodier, Simon Frédéric Dufresne , Lambert Busque , Sylvie Lachance , Guy Sauvageau , Sandra Cohen , Jean-Sébastien Delisle
    DOI 10.1016/j.bbmt.2020.09.031 PMID 33022376
    Consulter
  • A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

    Roy F Chemaly, Sanjeet S Dadwal, Anne Bergeron, Per Ljungman, Yae-Jean Kim, Guang-Shing Cheng, Sudhakar N Pipavath, Ajit P Limaye, Elodie Blanchard, Drew J Winston, Patrick J Stiff, Tsila Zuckerman , Sylvie Lachance , Galia Rahav, Catherine B Small, Kathleen M Mullane, Roberto L Patron, Dong-Gun Lee, Hans H Hirsch, Alpana Waghmare, Matt McKevitt, Robert Jordan, Ying Guo, Polina German , Danielle P Porter, David L Gossage, Timothy R Watkins, Francisco M Marty, Jason W Chien, Michael Boeckh
    DOI 10.1093/cid/ciz1166 PMID 31793991
    Consulter
  • Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors

    DOI 10.1111/ejh.13504 PMID 32749758
    Consulter
  • Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only

    DOI 10.1111/ctr.14099 PMID 32981146
    Consulter
  • ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia

    Denis-Claude Roy , Irwin Walker, Johan Maertens, Philippe Lewalle, Eduardo Olavarria, Dominik Selleslag , Sylvie Lachance , Marc Buyse, Kun Wang, Jeroen Rovers, Irene Santi, Halvard Bonig, Andrew Sandler, Jurjen Velthuis, Stephan Mielke
    DOI 10.1038/s41375-020-0733-0 PMID 32047237
    Consulter
  • Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group

    Mohamad Mohty, Florent Malard, Manuel Abecasis, Erik Aerts, Ahmed S. Alaskar, Mahmoud Aljurf, Mutlu Arat, Peter Bader, Frederic Baron, Grzegorz Basak, Ali Bazarbachi, Didier Blaise, Fabio Ciceri , Selim Corbacioglu, Jean-Hugues Dalle, Fiona Dignan, Takahiro Fukuda, Anne Huynh, Jurgen Kuball , Sylvie Lachance , Hillard Lazarus, Tamas Masszi, Mauricette Michallet, Arnon Nagler, Mairead NiChonghaile, Shinichiro Okamoto, Antonio Pagliuca, Christina Peters, Finn B. Petersen, Paul G. Richardson, Tapani Ruutu , Wael Saber, Bipin N. Savani, Robert Soiffer, Jan Styczynski, Elisabeth Wallhult, Ibrahim Yakoub-Agha, Rafael F. Duarte, Enric Carreras
    DOI 10.1038/s41409-019-0705-z PMID 31576023
    Consulter
  • Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study

    Sandra Cohen , Jean Roy , Sylvie Lachance , Jean-Sébastien Delisle , Anne Marinier , Lambert Busque , Denis-Claude Roy , Imran Ahmad , Nadia M Bambace , Léa Bernard , Thomas Kiss , Philippe Bouchard, Pierre Caudrelier, Sévérine Landais, Fannie Larochelle, Jalila Chagraoui, Bernhard Lehnertz, Sophie Corneau, Elisa Tomellini, Jeroen J A van Kampen, Jan J Cornelissen, Maude Dumont-Lagacé, Mégane Tanguay, Qi Li , Sébastien Lemieux, Peter W Zandstra , Guy Sauvageau
    DOI 10.1016/S2352-3026(19)30202-9 PMID 31704264
    Consulter
  • Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma

    DOI 10.1016/j.bbmt.2019.09.007 PMID 31521818
    Consulter
  • Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis

    Denis-Claude Roy , Sylvie Lachance , Sandra Cohen , Jean-Sébastien Delisle , Thomas Kiss , Guy Sauvageau , Lambert Busque , Imran Ahmad , Léa Bernard , Nadia M Bambace, Radia S Boumédine, Marie-Claude Guertin, Katayoun Rezvani, Stephan Mielke, Claude Perreault , Jean Roy
    DOI 10.1111/bjh.15970 PMID 31135970
    Consulter
  • Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease

    DOI 10.1016/j.leukres.2019.01.002 PMID 30654975
    Consulter
  • Cerebral adenovirus endotheliitis presenting as posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation

    DOI 10.1038/bmt.2017.154 PMID 28692025
    Consulter
  • CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft- versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results

    Amina Kariminia, Sabine Ivison, Bernard Ng, Jacob Rozmus, Susanna Sung, Avani Varshney, Mahmoud Aljurf , Sylvie Lachance , Irwin Walker, Cindy Toze, Jeff Lipton, Stephanie J Lee, Jeff Szer, Richard Doocey, Ian Lewis, Clayton Smith, Naeem Chaudhri, Megan K Levings, Raewyn Broady, Gerald Devins, David Szwajcer, Ronan Foley , Sara Mostafavi, Steven Pavletic, Donna A Wall, Stephan Couban, Tony Panzarella, Kirk R Schultz
    DOI 10.3324/haematol.2017.170928 PMID 28935847
    Consulter
  • Opportunities and challenges for the cellular immunotherapy sector: a global landscape of clinical trials

    Katherine Bonter, Zackariah Breckenridge , Sylvie Lachance , Jean-Sébastien Delisle , Tania Bubela
    DOI 10.2217/rme-2017-0031 PMID 28850001
    Consulter
  • More Haste, Less Speed: Could Public-Private Partnerships Advance Cellular Immunotherapies?

    Tania Bubela, Katherine Bonter , Sylvie Lachance , Jean-Sébastien Delisle , E Richard Gold
    DOI 10.3389/fmed.2017.00134 PMID 28861415
    Consulter
  • Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-Learning

    Elizabeth F Krakow, Michael Hemmer, Tao Wang, Brent Logan, Mukta Arora, Stephen Spellman, Daniel Couriel, Amin Alousi, Joseph Pidala, Michael Last , Sylvie Lachance , Erica E M Moodie
    DOI 10.1093/aje/kwx027 PMID 28472335
    Consulter
  • The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation

    Bertrand Routy , Caroline Letendre , David Enot, Maxime Chénard-Poirier, Vikram Mehraj, Noémie Charbonneau Séguin, Khaled Guenda, Kathia Gagnon, Paul-Louis Woerther, David Ghez , Sylvie Lachance
    DOI 10.1080/2162402X.2016.1258506 PMID 28197380
    Consulter
  • Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study

    Stephen Couban, Mahmoud Aljurf , Sylvie Lachance , Irwin Walker, Cynthia Toze, Morel Rubinger, Jeffrey H Lipton, Stephanie J Lee, Jeff Szer, Richard Doocey, Ian D Lewis, Lothar Huebsch, Kang Howson-Jan, Michel Lalancette, Fahad Almohareb , Nadeem Chaudhri, Sabine Ivison, Raewyn Broady, Megan Levings, Diane Fairclough, Gerald Devins, David Szwajcer, Ronan Foley, Clayton Smith, Tony Panzarella, Holly Kerr, Amina Kariminia, Kirk R Schultz
    DOI 10.1016/j.bbmt.2016.04.017 PMID 27154847
    Consulter
  • Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation

    DOI 10.1038/bmt.2015.319 PMID 26691426
    Consulter
  • A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemia

    Sylvie Lachance , A L Christofides, J K Lee, L H Sehn, B C Ritchie, C Shustik, D A Stewart, C L Toze, E Haddad, D C Vinh
    DOI 10.3747/co.23.2810 PMID 26966403
    Consulter
  • Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatment

    DOI 10.1016/j.blre.2014.08.002 PMID 25228333
    Consulter
  • Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study

    Tayfun Güngör, Pierre Teira, Mary Slatter, Georg Stussi, Polina Stepensky, Despina Moshous, Clementien Vermont , Imran Ahmad , Peter J Shaw, José Marcos Telles da Cunha, Paul G Schlegel, Rachel Hough, Anders Fasth, Karim Kentouche, Bernd Gruhn, Juliana F Fernandes , Sylvie Lachance , Robbert Bredius, Igor B Resnick, Bernd H Belohradsky, Andrew Gennery, Alain Fischer, H Bobby Gaspar, Urs Schanz, Reinhard Seger, Katharina Rentsch, Paul Veys, Elie Haddad , Michael H Albert, Moustapha Hassan; Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation
    DOI 10.1016/S0140-6736(13)62069-3 PMID 24161820
    Consulter